Carlos Lucente
Global Head of Finance at Sandoz | Basel, Basel, Switzerland
Carlos Lucente’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Global Head of Finance at Sandoz in November 2024 - Present
CFO Europe at Sandoz in November 2022 - February 2025
CFO Biopharmaceuticals at Sandoz in February 2022 - November 2022
Head Controlling Global Technical Operations & Finance Head Quality & Supply Chain at Novartis in January 2021 - January 2022
Head Controlling Global Technical Operations at Novartis in July 2018 - January 2021
Commercial Excellence Head - Pharma Argentina at Novartis in November 2016 - July 2018
Country CFO Argentina y Uruguay at Novartis in April 2015 - July 2018
CFO Sandoz Brazil at Sandoz in May 2013 - April 2015
Head Business Planning & Analysis - Pharma Spain at Novartis in September 2011 - April 2013
Head Business Planning & Analysis - Sandoz Spain at Sandoz in May 2011 - September 2011
BPA (Controller) at Novartis in October 2009 - May 2011
Plant Controller (BPA) at Novartis in May 2007 - November 2009
Business Process Controller at Novartis in March 2006 - May 2007
SOX Implementation Project at HSBC in February 2005 - July 2005
Senior Business Risk Services at Ernst & Young in June 2004 - February 2005
Experienced Auditor at Arthur Andersen in December 2000 - February 2003
Harvard Business School Executive Education, January 2018
Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. Read our community engagement guidelines: http://bit.ly/4ofoggc
Discover more about Sandoz
Global QC/AS&T SETLAB Manager| Digital Quality Solutions
Global QC/AS&T SETLAB Manager at Sandoz
(August 2024 – Present)
Chief Scientific Officer, Sandoz - Pioneering access for patients responsibly and sustainably
Chief Scientific Officer at Sandoz
(July 2022 – Present)
Head Maintenance Regulatory Center, Hyderabad at Sandoz
Head Regulatory Generics Lifecycle and International Submissions (RGLI) - Hyderabad at Sandoz
(November 2019 – Present)
L&D Lead - Learning Platforms, Assessments & Credentials
L&D Lead - Learning Platforms, Assessments & Credentials at Dr. Reddy's Laboratories
(April 2024 – Present)
Clinical Development | Clinical Strategy Manager | Clinical Project Management | Pharmacokinetics
Clinical Strategy Manager at Lotus Pharmaceutical Co., Ltd
(November 2024 – Present)
Global Head Patient Safety
Global Head Patient Safety at Sandoz
(August 2021 – Present)
What is Carlos Lucente email address?
Email Carlos Lucente at [email protected] and [email protected]. This email is the most updated Carlos Lucente's email found in 2026.
How to contact Carlos Lucente?
To contact Carlos Lucente send an email to [email protected] or [email protected].
What company does Carlos Lucente work for?
Carlos Lucente works for Sandoz.
What is Carlos Lucente's role at Sandoz?
Carlos Lucente is Global Head of Finance
What industry does Carlos Lucente work in?
Carlos Lucente works in the Pharmaceuticals industry.
